NO179602C - Use of a NADH or NADPH in the preparation of an antidepressant - Google Patents
Use of a NADH or NADPH in the preparation of an antidepressantInfo
- Publication number
- NO179602C NO179602C NO920056A NO920056A NO179602C NO 179602 C NO179602 C NO 179602C NO 920056 A NO920056 A NO 920056A NO 920056 A NO920056 A NO 920056A NO 179602 C NO179602 C NO 179602C
- Authority
- NO
- Norway
- Prior art keywords
- antidepressant
- nadh
- nadph
- preparation
- adenine dinucleotide
- Prior art date
Links
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 title abstract 3
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 title 1
- 230000001430 anti-depressive effect Effects 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 title 1
- 229940005513 antidepressants Drugs 0.000 title 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 title 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 abstract 1
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 abstract 1
- 229950006238 nadide Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The use of nicotinamide adenine dinucleotide, nicotinamide adenine dinucleotide phosphate or of a physiologically tolerated salt thereof for the treatment of depression.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4100361A DE4100361C1 (en) | 1991-01-04 | 1991-01-04 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO920056D0 NO920056D0 (en) | 1992-01-03 |
| NO920056L NO920056L (en) | 1992-07-06 |
| NO179602B NO179602B (en) | 1996-08-05 |
| NO179602C true NO179602C (en) | 1996-11-13 |
Family
ID=6422686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO920056A NO179602C (en) | 1991-01-04 | 1992-01-03 | Use of a NADH or NADPH in the preparation of an antidepressant |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0493861B1 (en) |
| JP (1) | JP2519148B2 (en) |
| AT (1) | ATE148991T1 (en) |
| AU (1) | AU631755B2 (en) |
| BR (1) | BR9105183A (en) |
| CA (1) | CA2057456C (en) |
| DE (2) | DE4100361C1 (en) |
| DK (1) | DK0493861T3 (en) |
| ES (1) | ES2097181T3 (en) |
| GR (1) | GR3022724T3 (en) |
| HU (1) | HU213112B (en) |
| IE (1) | IE914477A1 (en) |
| NO (1) | NO179602C (en) |
| PT (1) | PT99962B (en) |
| ZA (1) | ZA9244B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2735293A1 (en) * | 1995-01-17 | 1996-07-18 | Menuco Corp. | Nadh and nadph therapeutic agents for dermal administration |
| US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
| US5668114A (en) * | 1996-05-08 | 1997-09-16 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating hypertension |
| ES2953842B2 (en) * | 2023-07-17 | 2025-02-14 | Nuadi Europe S L | DUSTPROOF HUB COVERS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3341412A (en) * | 1966-03-04 | 1967-09-12 | Enzomedic Lab Inc | Methods of treating schizophrenia |
| EP0331620B1 (en) * | 1988-03-01 | 1993-08-11 | Birkmayer, Walther, Prof. Dr. | Agent for the treatment of parkinson's disease |
-
1991
- 1991-01-04 DE DE4100361A patent/DE4100361C1/de not_active Expired - Lifetime
- 1991-11-07 EP EP91250304A patent/EP0493861B1/en not_active Expired - Lifetime
- 1991-11-07 AT AT91250304T patent/ATE148991T1/en not_active IP Right Cessation
- 1991-11-07 ES ES91250304T patent/ES2097181T3/en not_active Expired - Lifetime
- 1991-11-07 DK DK91250304.2T patent/DK0493861T3/en active
- 1991-11-07 DE DE59108553T patent/DE59108553D1/en not_active Expired - Fee Related
- 1991-11-28 BR BR919105183A patent/BR9105183A/en not_active Application Discontinuation
- 1991-12-10 CA CA002057456A patent/CA2057456C/en not_active Expired - Fee Related
- 1991-12-20 IE IE447791A patent/IE914477A1/en not_active IP Right Cessation
- 1991-12-27 JP JP3346474A patent/JP2519148B2/en not_active Expired - Fee Related
- 1991-12-31 AU AU90109/91A patent/AU631755B2/en not_active Ceased
-
1992
- 1992-01-02 PT PT99962A patent/PT99962B/en not_active IP Right Cessation
- 1992-01-03 ZA ZA9244A patent/ZA9244B/en unknown
- 1992-01-03 NO NO920056A patent/NO179602C/en not_active IP Right Cessation
- 1992-01-03 HU HU9200025A patent/HU213112B/en not_active IP Right Cessation
-
1997
- 1997-03-03 GR GR970400414T patent/GR3022724T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE59108553D1 (en) | 1997-03-27 |
| NO920056D0 (en) | 1992-01-03 |
| ZA9244B (en) | 1992-10-28 |
| JPH05139978A (en) | 1993-06-08 |
| IE914477A1 (en) | 1992-07-15 |
| GR3022724T3 (en) | 1997-06-30 |
| HUT60141A (en) | 1992-08-28 |
| ES2097181T3 (en) | 1997-04-01 |
| EP0493861A2 (en) | 1992-07-08 |
| HU9200025D0 (en) | 1992-03-30 |
| PT99962B (en) | 1999-06-30 |
| EP0493861B1 (en) | 1997-02-19 |
| BR9105183A (en) | 1992-09-29 |
| JP2519148B2 (en) | 1996-07-31 |
| DE4100361C1 (en) | 1992-04-23 |
| HU213112B (en) | 1997-02-28 |
| CA2057456C (en) | 1996-02-06 |
| NO920056L (en) | 1992-07-06 |
| NO179602B (en) | 1996-08-05 |
| CA2057456A1 (en) | 1992-07-05 |
| DK0493861T3 (en) | 1997-08-25 |
| PT99962A (en) | 1993-02-26 |
| AU631755B2 (en) | 1992-12-03 |
| EP0493861A3 (en) | 1993-03-03 |
| AU9010991A (en) | 1992-07-16 |
| ATE148991T1 (en) | 1997-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0697859T3 (en) | Stable, oral and absorbable therapeutic preparations of NADP and NADPH | |
| AU674463B2 (en) | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof | |
| NO933321D0 (en) | NADH AND NADPH AS A MEDICINE FOR TREATMENT OF MOBUS ALZHEIMER | |
| FI886050A7 (en) | Amperometric method for the quantitative determination of 1,4-dihydronicotinamide adenine dinucleotide (NADH) in solution | |
| EP0345248A3 (en) | Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof | |
| NO179602C (en) | Use of a NADH or NADPH in the preparation of an antidepressant | |
| FI920323A0 (en) | NADH OCH NADPH SOM ENERGISUBSTITUT. | |
| NO923324L (en) | MEDICINE FOR CANCER OR AIDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN JULY 2003 |